Jaguar Health Approves Sixfold Increase to 2014 Plan Share Reserve
Jaguar Health approved a sixfold increase to its 2014 Stock Incentive Plan share reserve, effective after a November 6 meeting. If Proposal 3 is approved, the reserve will be 2,273,154 shares; if not, it will be 4,260 shares. Maximum shares issuable through incentive stock options will be 163,998 in either case, according to the company.
How this was made

The 30-second read
Why it matters
The filing expands the pool of shares available for future option grants, which may dilute existing shareholders but could also support talent retention.
Market read
A corporate action that modestly increases dilution risk for shareholders of JAGX.
What to watch
Potential for the company to limit actual issuances below the maximum, reducing dilution risk.
Background
Jaguar Health is a micro‑cap biotech that filed an 8‑K to adjust its stock incentive plan following a Series R preferred dividend.
Ticker impact
Jaguar Health filed an 8‑K announcing a sixfold increase to its 2014 Stock Incentive Plan share reserve, changing the potential pool of issuable shares.
likely modest downward pressure as the market prices in potential dilution
The filing is the first public disclosure of the reserve change and directly expands the pool of shares that could be issued through options.
Market effects
Minimal impact on the broader biotech sector; the change is company‑specific.
Limited to U.S. investors holding JAGX.
Low
Counterpoint
If the increased reserve is used for strategic hires or acquisitions, the dilution could be offset by future growth.
Key entities
- companyJaguar Health, Inc.
Issuer of the stock incentive plan adjustment.